Treating to Target in Hidradenitis Suppurativa: Canadian Perspectives

Gulliver, Wayne
Turchin, Irina
Brown-Maher, Tracey
Wiseman, Marni
Lam, Lauren
Asgarpour, Jessica
Alhusayen, Raed

¹Division of Dermatology, Memorial University, St. John's, Newfoundland, Canada
²NewLab Clinical Research, St. John's, Newfoundland, Canada
³Brunswick Dermatology Center, Fredericton, New Brunswick, Canada
⁴Probity Medical Research, Waterloo, Ontario, Canada
⁵Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada
⁶NL Clinical Trials Inc, St. John's, Newfoundland, Canada
⁷Division of Dermatology, Department of Internal Medicine, Memorial University, St. John's, Newfoundland, Canada
⁸Department of Medicine, Section of Dermatology, SKiNWISE Dermatology and Wiseman Dermatology Research, University of Manitoba, Winnipeg, Manitoba, Canada
⁹Beacon Dermatology, Calgary, AB; Probity Medical Research, Waterloo, Ontario, Canada
¹⁰Women's College Hospital, Toronto, Ontario, Canada
¹¹Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
¹²Sunnybrook Research Institute, Toronto, Ontario, Canada

^*Correspondence: Irina Turchin ([email protected])

Received June 13, 2025; Revised August 08, 2025; Accepted August 26, 2025

This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

Jeadv Clinical Practice Publish Ahead of Print, September 12, 2025. | DOI: 10.1002/jvc2.70172